{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': '2642 Michelle Drive',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 7.13,
 'askSize': 1800,
 'averageDailyVolume10Day': 422775,
 'averageVolume': 422487,
 'averageVolume10days': 422775,
 'beta': 2.234733,
 'beta3Year': None,
 'bid': 6.71,
 'bidSize': 800,
 'bookValue': 0.742,
 'category': None,
 'circulatingSupply': None,
 'city': 'Tustin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.03,
 'dayLow': 6.77,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -49.961,
 'enterpriseToRevenue': 6.271,
 'enterpriseValue': 374405696,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 6.504,
 'fiftyTwoWeekHigh': 8.38,
 'fiftyTwoWeekLow': 3.02,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 39520043,
 'forwardEps': 0.04,
 'forwardPE': 169.75,
 'fromCurrency': None,
 'fullTimeEmployees': 222,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.07337,
 'heldPercentInstitutions': 0.58055997,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1588204800,
 'lastMarket': None,
 'lastSplitDate': 1499644800,
 'lastSplitFactor': '1:7',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/avidbio.com',
 'longBusinessSummary': 'Avid Bioservices, Inc., a contract development and '
                        'manufacturing organization, provides process '
                        'development and current good manufacturing practices '
                        '(CGMP) clinical and commercial manufacturing services '
                        'focused on biopharmaceutical drug substances derived '
                        'from mammalian cell culture. It produces monoclonal '
                        'antibodies and recombinant proteins; and offers '
                        'services, including CGMP clinical and commercial drug '
                        'substance manufacturing, purification, bulk '
                        'packaging, release and stability testing, and '
                        'regulatory submission and support. The company also '
                        'provides various process development services, such '
                        'as upstream and downstream development and '
                        'optimization, analytical methods development, '
                        'testing, and characterization. It serves '
                        'biotechnology and pharmaceutical companies. The '
                        'company was formerly known as Peregrine '
                        'Pharmaceuticals, Inc. and changed its name to Avid '
                        'Bioservices, Inc. in January 2018. Avid Bioservices, '
                        'Inc. was founded in 1981 and is headquartered in '
                        'Tustin, California.',
 'longName': 'Avid Bioservices, Inc.',
 'market': 'us_market',
 'marketCap': 383711712,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_189510',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1588204800,
 'navPrice': None,
 'netIncomeToCommon': -15152000,
 'nextFiscalYearEnd': 1651276800,
 'open': 6.91,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -3.1,
 'phone': '714 508 6100',
 'previousClose': 6.98,
 'priceHint': 2,
 'priceToBook': 9.150944,
 'priceToSalesTrailing12Months': 6.4271164,
 'profitMargins': -0.1753,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.03,
 'regularMarketDayLow': 6.77,
 'regularMarketOpen': 6.91,
 'regularMarketPreviousClose': 6.98,
 'regularMarketPrice': 6.91,
 'regularMarketVolume': 200068,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 56511300,
 'sharesPercentSharesOut': 0.0427,
 'sharesShort': 2412177,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2040729,
 'shortName': 'Avid Bioservices, Inc.',
 'shortPercentOfFloat': 0.0428,
 'shortRatio': 5.9,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'CDMO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.269,
 'twoHundredDayAverage': 5.943741,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'a0fc0136-42be-36de-81a3-35bc25628d0f',
 'volume': 200068,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://avidbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92780'}